Medasense Biometrics Ltd. | 6,799 followers on LinkedIn. NOL-Nociception Level Index® - AI-driven technology transforming personalized PAIN monitoring and management. | Medasense is transforming the way PAIN is being assessed and treated worldwide. Through our breakthrough NOL® AI technology and sensing platform, we quantify pain response to optimize care and avoid overmedication. Medasense’s flagship product, PMD-200™, is used in critical care settings, where patients are unable to communicate, to visualize pain response and personalize treatment.